Clinical Trials List
2023-01-01 - 2028-11-30
Phase III
Recruiting13
ICD-10Z85.3
Personal history of malignant neoplasm of breast
ICD-9V10.3
Personal history of malignant neoplasm of breast
-
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/14
Investigators and Locations
Co-Principal Investigator
- Chi-Cheng Huang Division of General Surgery
- 陳彥蓁 Division of General Surgery
- 賴亦貞 Division of General Surgery
- 邱仁輝 Division of General Surgery
- Ta-Chung Chao Division of General Surgery
- 馮晉榮 Division of General Surgery
- Yi-Fang Tsai Division of General Surgery
- Chun-Yu Liu Division of General Surgery
- 林燕淑 Division of General Surgery
- Jiun-I Lai Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yao-Chung Wu Division of General Surgery
- Chen-Teng Wu Division of General Surgery
- 黃至豪 Division of General Surgery
- Chih-Jung Chen Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wei-Wen Chang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 甘蓉瑜 Division of General Surgery
- Junping Shiau Shiau Division of General Surgery
- Shen Liang Shih Division of General Surgery
- Chung-Liang Li Division of General Surgery
- Fang-Ming Chen 未分科
- 高理鈞 Division of General Surgery
- 高捷妮 Division of General Surgery
- Chieh-Han Chuang Division of General Surgery
- 巫承哲 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 沈士哲 未分科
- Yung-Chang Lin 未分科
- 阮昱翔 未分科
- Chi-Chang Yu 未分科
- Wen-Chi Shen 未分科
- Wen-Ling Kuo 未分科
- Mengting Peng 未分科
- 周旭桓 未分科
- Chan-Keng Yang 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shau-Hsuan Li Division of Hematology & Oncology
- 陳彥豪 Division of Hematology & Oncology
- 吳佳哲 Division of Hematology & Oncology
- 郭明濬 Division of Hematology & Oncology
- 陳彥仰 Division of Hematology & Oncology
- Yu-Li Su Division of Hematology & Oncology
- 黃詩喻 Division of Hematology & Oncology
- 陳秉聰 Division of Hematology & Oncology
- Tai-Jan Chiu Division of Hematology & Oncology
- 李易濰 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Kuo-Ting Lee 未分科
- Jui-Hung Tsai 未分科
- Yao-Lung Kuo Division of Hematology & Oncology
- Chun-Hui Lee 未分科
- Zhu-Jun Loh Division of Hematology & Oncology
- 楊舜如 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林建良 Division of Hematology & Oncology
- 曹朝榮 Division of Hematology & Oncology
- 林正耀 Division of Hematology & Oncology
- 高婉真 Division of Hematology & Oncology
- 黃文聰 Division of Hematology & Oncology
- 陳彥勳 Division of Hematology & Oncology
- 陳昭勳 Division of Hematology & Oncology
- 蕭聖諺 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳怡君 未分科
- YEN-SHEN LU Division of General Surgery
- 張端瑩 未分科
- 羅喬 Division of General Surgery
- MING-YANG WANG Division of General Surgery
- Wei-Wu Chen Division of General Surgery
- 郭文宏 未分科
- 林季宏 Division of General Surgery
- 陳怡君 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
105 participants
-
Global
560 participants
